首页> 外文期刊>Neuroscience: An International Journal under the Editorial Direction of IBRO >Differing influences of dopamine agonists and antagonists on Fos expression in identified populations of globus pallidus neurons.
【24h】

Differing influences of dopamine agonists and antagonists on Fos expression in identified populations of globus pallidus neurons.

机译:在确定的苍白球神经元群体中,多巴胺激动剂和拮抗剂对Fos表达的不同影响。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Dopamine agonists increase the activity of globus pallidus neurons, as shown electrophysiologically and with Fos expression. More recently it has been shown that decreased D2 receptor activity also causes pallidal Fos expression. Similar responses occur in the striatum, where both dopamine agonists and D2 blockade induce Fos, although in separate neuronal populations (i.e. striatonigral and -pallidal). The present experiments investigate the possible differential dopaminergic regulation of Fos within pallidal neuronal populations, which were classified as parvalbumin-positive or -negative (with parvalbumin immunostaining), or as projecting to various target nuclei (with retrograde transport of FluoroGold iontophoresed into these nuclei). Rats with prior nigrostriatal lesions received saline, D1 agonist, or D2 agonist. Rats with no lesions received saline, combined D1/D2 agonists, or the D2 antagonist eticlopride. Two hours after drug injection, rats were perfused and their brains processed for double-labeling: either Fos staining with parvalbumin staining, or Fos or parvalbumin staining in FluoroGold-labeled sections. Overall, dopamine drug treatments induced more Fos in parvalbumin-negative than -positive cells. However, unlike dopamine agonists, eticlopride induced significant Fos only in the parvalbumin-negative cells. Dopamine agonist-induced Fos was found in pallidal neurons projecting to each of the target nuclei examined, in both normal and nigrostriatal-lesioned rats. Eticlopride-induced Fos occurred only in pallidal neurons projecting to the striatum, providing functional evidence for pallidostriatal cells without axon collaterals to other nuclei. It was also found that pallidostriatal neurons were distinguished from other projection populations by a relative lack of parvalbumin immunoreactivity. Pallidal cells respond heterogeneously to dopaminergic treatments based on their projection target and expression of parvalbumin. The smaller Fos responses in parvalbumin-containing cells may be due largely to the calcium buffering by the parvalbumin itself. Also, the pattern of Fos expression in pallidostriatal neurons suggests that dopamine regulates activity in these cells differently than in other projection populations.
机译:多巴胺激动剂可增强苍白球神经元的活性,如电生理学和Fos表达所示。最近,已经显示出降低的D2受体活性也引起苍白的Fos表达。尽管在单独的神经元群体(即纹状体和复盖神经区)中,多巴胺激动剂和D2阻滞均可诱导Fos,在纹状体中也会发生类似的反应。本实验研究了苍白神经元群体中Fos的可能的多巴胺能多巴胺能调节差异,这些神经元被分类为小白蛋白阳性或阴性(小白蛋白免疫染色),或投射到各种靶细胞核(通过荧光金离子电泳逆行转运到这些核中)。 。先前患有黑纹状体病变的大鼠接受了盐水,D1激动剂或D2激动剂。无损伤的大鼠接受盐水,D1 / D2激动剂联合治疗或D2拮抗剂依替普利治疗。药物注射后两个小时,对大鼠进行灌注,并对其大脑进行双标记处理:用小白蛋白染色进行Fos染色,或在FluoroGold标记的切片中进行Fos或小白蛋白染色。总体而言,多巴胺药物治疗在小白蛋白阴性细胞中诱导的Fos大于阳性细胞。但是,与多巴胺激动剂不同,艾替洛必利仅在小白蛋白阴性细胞中诱导明显的Fos。在正常和黑质纹状体损伤的大鼠中,多巴胺激动剂诱导的Fos均在投射到所检查的每个靶核的苍白神经元中发现。依替普利特诱导的Fos仅发生在投射至纹状体的苍白神经元中,为苍白造口细胞提供功能证据,而无其他核的轴突侧支。还发现,由于相对缺乏小白蛋白免疫反应性,苍白神经元神经元与其他投射人群有所区别。苍白细胞根据其投射目标和小白蛋白的表达对多巴胺能治疗产生异质反应。含小白蛋白的细胞中较小的Fos反应可能主要是由于小白蛋白自身对钙的缓冲作用。同样,苍白口神经元中Fos表达的模式表明,多巴胺调节这些细胞中的活性的方式与其他投射人群不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号